'On our park-like campus just northeast of Los Angeles, City of Hope cancer research hospital brings groundbreaking cancer and diabetes research and compassionate care under one roof. National Cancer Institute comprehensive cancer treatment center.' /
DiaCarta provides innovative gene mutation testing technologies to improve the effectiveness of cures for cancers such as cervical cancer and head and neck cancer. DiaCarta’s NRAS and KRAS mutation test kits are high precision and widely used by hospitals
Boehringer Ingelheim ranks among the world's leading pharmaceutical companies, focusing on prescription medicines, consumer health care, chemicals, biopharmaceuticals and animal health.
DSF molecular diagnostic lab introduces two novel technologies, DSE and DSF, for sensitive and high throughput mutation screening for early detection of cancer, mrd and drug resistance. Physicians, pathologists and international investors are invited for
Translational lung cancer research (TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) publishes articles that describe new findings in the field of translational research in lung cancer, provides current and practical information
Translational lung cancer research (TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) publishes articles that describe new findings in the field of translational research in lung cancer, provides current and practical information
DSF molecular diagnostic lab offers our proprietary DSE and DSF assays for sensitive and high hroughput mutation screening assays for cancer genes. These two innovative technologies are soon entering the national phase of PCT patent application. We are se